Selvita strengthens management structure in sales and drug development segment

Go back to Selvita strengthens management structure in sales and drug development segment
ISHARES SILVER TRUST (NYSE: SLV) Delayed: 61.59 -0.73 (1.17%)
Previous Close $62.32    52 Week High $19.71 
Open $61.59    52 Week Low $13.04 
Day High $61.96    P/E N/A 
Day Low $61.02    EPS $0.00 
Volume 12,525,321       

ISHARES SILVER TRUST (NYSE: SLV) Delayed: 61.59 -0.73 (1.17%)
Previous Close $62.32    52 Week High $19.71 
Open $61.59    52 Week Low $13.04 
Day High $61.96    P/E N/A 
Day Low $61.02    EPS $0.00 
Volume 12,525,321